Palvella Therapeutics (PVLA) Change in Cash (2013 - 2026)
Palvella Therapeutics' (PVLA) quarterly Change in Cash came in at $148.4 million in Q1 2026, up 1960.73% year-on-year from $7.2 million in Q1 2025, and up 2757.33% on a QoQ basis from -$5.6 million in Q4 2025.
Palvella Therapeutics (PVLA) Change in Cash (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of Change in Cash data on file, last reported at $148.4 million in Q1 2026.
- On a quarterly basis, Change in Cash rose 1960.73% year-over-year to $148.4 million in Q1 2026; TTM through Mar 2026 was $130.8 million, a 88.49% increase from a year earlier, with the FY2025 full-year figure at -$25.6 million, down 133.6% from the prior year.
- Change in Cash for Q1 2026 stood at $148.4 million, up from -$5.6 million in the prior quarter.
- Over the last five years, Change in Cash for PVLA reached as high as $148.4 million in Q1 2026 and fell as low as -$34.0 million in Q1 2022.
- Historically, Change in Cash has averaged $6.5 million across 5 years, with a median of -$5.2 million in 2025.
- Across the five-year window, Change in Cash soared 2442.84% in 2024 and slumped 1980.61% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$9.8 million in 2022, then soared by 69.74% to -$3.0 million in 2023, then surged by 2442.84% to $69.4 million in 2024, then sank by 108.05% to -$5.6 million in 2025, then soared by 2757.33% to $148.4 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $148.4 million in Q1 2026, -$5.6 million in Q4 2025, and -$6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | 148.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.41 Mn |
| Dec 31, 2025 | -5.59 Mn |
| Sep 30, 2025 | -6.87 Mn |
| Jun 30, 2025 | -5.19 Mn |
| Mar 31, 2025 | -7.98 Mn |
| Dec 31, 2024 | 69.40 Mn |
| Sep 30, 2024 | -330,000.00 |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -2.96 Mn |
| Sep 30, 2023 | -12.04 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -5.83 Mn |
| Jun 30, 2022 | -29.48 Mn |
| Mar 31, 2022 | -34.03 Mn |
| Dec 31, 2021 | -7.29 Mn |
| Sep 30, 2021 | 5.96 Mn |
| Jun 30, 2021 | 52.26 Mn |